7.04 -0.17 (-2.36%)
NKTR
| Trade NKTR now with |
|
Stock Details
Last Trade:7.04 Change:-0.17 (-2.36%) Prev Close:7.21 Open: 7.19 Days Range:6.97 – 7.35 52 Week Range: 4.07 - 11.25 Volume:192177 P/E: N/AEPS:-1.10
View AllRecent Alerts 02/09/12
Recent Alert on 01/20/12 at 7:02am
BofA/Merrill Lynch Downgrades Nektar Therapeutics (NKTR) to Underperform
BofA/Merrill Lynch Downgrades Nektar Therapeutics (NKTR) to Underperform
BofA/Merrill Lynch downgraded Nektar Therapeutics (NASDAQ: NKTR) from Neutral to Underperform. For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click... Read More
Recent Alert on 01/20/12 at 7:02am
BofA/Merrill Lynch Downgrades Nektar Therapeutics (NKTR) to Underperform
BofA/Merrill Lynch Downgrades Nektar Therapeutics (NKTR) to Underperform
Recent Alert on 01/17/12 at 7:56am
ThinkEquity Downgrades Nektar Therapeutics (NKTR) to Sell, Reaffirms $5 Price Target
ThinkEquity Downgrades Nektar Therapeutics (NKTR) to Sell, Reaffirms $5 Price Target
Recent Alert on 12/13/11 at 7:31am
Nektar Therapeutics (NKTR) Reports Positive Clinical Data from Second Phase 1 Clinical Study of NKTR-181
Nektar Therapeutics (NKTR) Reports Positive Clinical Data from Second Phase 1 Clinical Study of NKTR-181
Recent Alert on 12/12/11 at 7:32am
Nektar (NKTR) Initiates NKTR-102 Phase 3 in Women with Metastatic Breast Cancer
Nektar (NKTR) Initiates NKTR-102 Phase 3 in Women with Metastatic Breast Cancer
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available